Lynx1 Capital discloses 5.4% Precision BioSciences (DTIL) ownership in Schedule 13G

Rhea-AI Filing Summary

Lynx1 Capital Management LP and Weston Nichols report beneficial ownership of shares of Precision BioSciences, Inc. common stock. Through Lynx1 Master Fund LP, they beneficially own 1,390,611 shares of common stock, with shared voting and dispositive power over all of these shares and no sole voting or dispositive power.

This position represents 5.4% of Precision BioSciences’ common stock, based on 25,802,247 shares outstanding as of April 30, 2026, as reported by the company. The Lynx1 Fund has the right to receive dividends and sale proceeds from the shares. The reporting persons state that their filing should not be construed as an admission of beneficial ownership for all purposes.

Key Figures

Beneficial ownership: 1,390,611 shares Percent of class: 5.4% Shares outstanding baseline: 25,802,247 shares +2 more

5 metrics

Beneficial ownership 1,390,611 shares Shares of Precision BioSciences common stock beneficially owned by Lynx1-related entities

Percent of class 5.4% Portion of Precision BioSciences common stock represented by the reported holdings

Shares outstanding baseline 25,802,247 shares Precision BioSciences common stock outstanding as of April 30, 2026

Sole voting power 0 shares Shares over which the reporting persons have sole voting power

Shared voting power 1,390,611 shares Shares over which the reporting persons have shared voting power

Key Terms

beneficial owner, shared voting power, sole dispositive power, shared dispositive power, +1 more

5 terms

beneficial owner regulatory

"the beneficial owner of the securities reported herein"

A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.

shared voting power regulatory

"Shared Voting Power 1,390,611.00"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

sole dispositive power regulatory

"Sole Dispositive Power 0.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

shared dispositive power regulatory

"Shared Dispositive Power 1,390,611.00"

percent of class regulatory

"Percent of class: 5.4%"

Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/20/2026 - 04:11 PM Accepted by SEC EDGAR 07/20/2026 - 04:10 PM Learn about SEC filing dates

FAQ

What percentage of Precision BioSciences (DTIL) does Lynx1 Capital report owning?

Lynx1 Capital Management LP and Weston Nichols report beneficial ownership of 5.4% of Precision BioSciences’ common stock. This percentage is based on 25,802,247 shares outstanding as of April 30, 2026, as disclosed by the company.

How many Precision BioSciences (DTIL) shares are beneficially owned by Lynx1-related entities?

Lynx1-related entities beneficially own 1,390,611 shares of Precision BioSciences common stock. These shares are held by Lynx1 Master Fund LP, with Lynx1 Capital Management LP and Weston Nichols reporting shared voting and dispositive power over the position.

Does Lynx1 Capital have sole or shared voting power over its DTIL shares?

Lynx1 Capital Management LP and Weston Nichols report 0 shares with sole voting power and 1,390,611 shares with shared voting power. They likewise report no sole dispositive power and shared dispositive power over the same number of shares.

What is the share count used to calculate Lynx1’s 5.4% stake in Precision BioSciences (DTIL)?

The reported 5.4% ownership stake is calculated using 25,802,247 shares of Precision BioSciences common stock outstanding. This outstanding share figure is as of April 30, 2026, based on the company’s Quarterly Report for the period ended March 31, 2026.

Who receives dividends and sale proceeds from Lynx1’s DTIL holdings?

The disclosure states that the Lynx1 Fund has the right to receive or direct the receipt of dividends and sale proceeds from the reported Precision BioSciences shares. Lynx1 Capital Management LP acts as investment manager to the Lynx1 Fund.

Who are the reporting persons in the Lynx1 Schedule 13G for Precision BioSciences (DTIL)?

The reporting persons are Lynx1 Capital Management LP, a Delaware limited partnership and investment manager to Lynx1 Master Fund LP, and Weston Nichols, the sole member of Lynx1 Capital Management GP LLC, the general partner of the investment manager.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

PRECISION BIOSCIENCES INC

(Name of Issuer)

Common Stock, par value $0.000005 per share

(Title of Class of Securities)

74019P207

(CUSIP Number)

07/13/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 74019P207

1

Names of Reporting Persons

Lynx1 Capital Management LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,390,611.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,390,611.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,390,611.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.4 %

12

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13G

CUSIP Number(s): 74019P207

1

Names of Reporting Persons

Weston Nichols

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,390,611.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,390,611.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,390,611.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.4 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: PRECISION BIOSCIENCES INC
(b)	Address of issuer's principal executive offices: 302 East Pettigrew St, Suite A-100, Durham, North Carolina 27701.
Item 2.
(a)	Name of person filing: This statement is filed by: (i) Lynx1 Capital Management LP (the "Investment Manager"), a Delaware limited partnership, and the investment manager to Lynx1 Master Fund LP (the "Lynx1 Fund"), with respect to the shares of common stock, par value $0.000005 per share ("Common Stock") of Precision BioSciences, Inc., a Delaware corporation (the "Company"), directly held by the Lynx1 Fund; and (ii) Mr. Weston Nichols ("Mr. Nichols"), the sole member of Lynx1 Capital Management GP LLC, the general partner of the Investment Manager, with respect to the shares of Common Stock directly held by the Lynx1 Fund. The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons." The filing of this statement should not be construed as an admission that any of the foregoing persons or any Reporting Person is, for the purposes of Section 13 of the Securities Exchange Act of 1934, the beneficial owner of the securities reported herein.
(b)	Address or principal business office or, if none, residence: Lynx1 Capital Management LP D81 Calle C Suite 301, PMB 1202 Dorado, PR, 00646-2051 Weston Nichols c/o Lynx1 Capital Management LP D81 Calle C Suite 301, PMB 1202 Dorado, PR, 00646-2051
(c)	Citizenship: Investment Manager - Delaware Mr. Nichols - United States of America
(d)	Title of class of securities: Common Stock, par value $0.000005 per share
(e)	CUSIP Number(s): 74019P207
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: The information required by Item 4(a) is set forth in Row 9 of the cover page for each of the Reporting Persons and is incorporated herein by reference. The percentage set forth in this Schedule 13G is calculated based upon an aggregate of 25,802,247 shares of Common Stock outstanding as of April 30, 2026, as reported in the Company's Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2026, filed with the Securities and Exchange Commission on May 5, 2026.
(b)	Percent of class: 5.4%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: The information required by Item 4(c)(i) is set forth in Row 5 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
	(ii) Shared power to vote or to direct the vote: The information required by Item 4(c)(ii) is set forth in Row 6 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
	(iii) Sole power to dispose or to direct the disposition of: The information required by Item 4(c)(iii) is set forth in Row 7 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
	(iv) Shared power to dispose or to direct the disposition of: The information required by Item 4(c)(iv) is set forth in Row 8 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. See Item 2(a). The Lynx1 Fund has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock reported herein.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Lynx1 Capital Management LP

Signature:	/s/ Weston Nichols
Name/Title:	By: Lynx1 Capital Management GP LLC, General Partner, By: Weston Nichols, Sole Member
Date:	07/20/2026

Weston Nichols

Signature:	/s/ Weston Nichols
Name/Title:	Weston Nichols, Individually
Date:	07/20/2026